US 11370789
Octahydro fused azadecalin glucocorticoid receptor modulators
granted A61PA61P35/00
Quick answer
US patent 11370789 (Octahydro fused azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P35/00